Hyepereosiniphilic syndrome and COVID-19: 2 case reports.

ABSTRACT:

Background

Nearly half of the patients with hypereosinophilic syndrome (HES) have cardiovascular involvement, a major cause of mortality. COVID-19 infection can lead to cardiac involvement, negatively impacting the clinical course and prognosis. We reported two patients with HES complicated by COVID-19, with cardiac involvement and valve replacement.

Case presentation

Our first patient was a 27-year-old woman admitted due to dyspnea and signs of heart failure. She had severe mitral stenosis and mitral regurgitation on the echocardiogram. Corticosteroid therapy improved her symptoms initially, but she deteriorated following a positive COVID-19 test. A repeated echocardiogram showed right ventricular failure, severe mitral regurgitation, and torrential tricuspid regurgitation

SUBMITTER: Sherafati A 

PROVIDER: S-EPMC10121068 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature